Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Prospective Registry to Evaluate the Safety and Efficacy of Minimally Invasive Ultrafiltration Treatment and Its Effect on Symptoms and Rehospitalisation in Patients With Advanced Volume Overload

NCT02769351 is registered in ClinicalTrials.gov with Fresenius Medical Care Deutschland GmbH as lead sponsor.

NCT NCT02769351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02769351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Prospective Registry to Evaluate the Safety and Efficacy of Minimally Invasive Ultrafiltration Treatment and Its Effect on Symptoms and Rehospitalisation in Patients With Advanced Volume Overload
Lead sponsor
Fresenius Medical Care Deutschland GmbH
Phase
Observational
Overall status
Terminated
Start date
December 3, 2015
Completion date
March 4, 2019
Enrollment
104 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

acute heart failure, cardiac decompensation, volume overload